FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

2009111000001107: Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1885861000001116 Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1885871000001114 Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule Is a Alfacalcidol 250nanogram capsules 30 capsule true Inferred relationship Existential restriction modifier
Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule Is pack of Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule Has active ingredient Alfacalcidol false Inferred relationship Existential restriction modifier
Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule Has AMP Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule Has specific active ingredient Alfacalcidol true Inferred relationship Existential restriction modifier
Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Alfacalcidol 250nanogram capsules (Kent Pharma (UK) Ltd) 30 capsule Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start